Valuing an early-stage biotechnology investment as a rainbow option.

Valuing an early-stage biotechnology investment as a rainbow option.

Opis bibliograficzny
Wydane w:Journal of Applied Corporate Finance V. 23, 1-4 (2011).
1. autor: Brous, Peter A.
Format: Artykuł
Język:English
Hasła przedmiotowe:
Biotechnology industry.
Business valuation.
Investments.
Risk assessment.
Securities prices.